AAAAAA

   
Results: 1-25 | 26-26
Results: 1-25/26
P53 GENE-THERAPY IN A RAT MODEL OF HEPATOCELLULAR-CARCINOMA - INTRAARTERIAL DELIVERY OF A RECOMBINANT ADENOVIRUS
Authors: ANDERSON SC JOHNSON DE HARRIS MP ENGLER H HANCOCK W HUANG WM WILLS KN GREGORY RJ SUTJIPTO S WEN SF LOFGREN S SHEPARD HM MANEVAL DC
Citation: Sc. Anderson et al., P53 GENE-THERAPY IN A RAT MODEL OF HEPATOCELLULAR-CARCINOMA - INTRAARTERIAL DELIVERY OF A RECOMBINANT ADENOVIRUS, Clinical cancer research, 4(7), 1998, pp. 1649-1659
STUDIES ON THE MOLECULAR MECHANISM OF GROWTH-INHIBITION WITH P53 ADENOVIRAL CONSTRUCT IN HUMAN OVARIAN-CANCER
Authors: MUJOO K CATINO JJ MANEVAL DC GUTTERMAN JU
Citation: K. Mujoo et al., STUDIES ON THE MOLECULAR MECHANISM OF GROWTH-INHIBITION WITH P53 ADENOVIRAL CONSTRUCT IN HUMAN OVARIAN-CANCER, International journal of gynecological cancer, 8(3), 1998, pp. 233-241
ENHANCEMENT OF ADENOVIRUS-MEDIATED GENE-TRANSFER TO HUMAN BONE-MARROWCELLS
Authors: WATANABE T KELSEY L AGEITOS A KUSZYNSKI C INO K HEIMANN DG VARNEY MT SHEPARD HM VAILLANCOURT MT MANEVAL DC TALMADGE JE
Citation: T. Watanabe et al., ENHANCEMENT OF ADENOVIRUS-MEDIATED GENE-TRANSFER TO HUMAN BONE-MARROWCELLS, Leukemia & lymphoma, 29(5-6), 1998, pp. 439-451
A RECOMBINANT ADENOVIRAL VECTOR EXPRESSING FULL-LENGTH HUMAN RETINOBLASTOMA SUSCEPTIBILITY GENE INHIBITS HUMAN TUMOR-CELL GROWTH
Authors: DEMERS GW HARRIS MP WEN SF ENGLER H NIELSEN LL MANEVAL DC
Citation: Gw. Demers et al., A RECOMBINANT ADENOVIRAL VECTOR EXPRESSING FULL-LENGTH HUMAN RETINOBLASTOMA SUSCEPTIBILITY GENE INHIBITS HUMAN TUMOR-CELL GROWTH, Cancer gene therapy, 5(4), 1998, pp. 207-214
P53 TUMOR-SUPPRESSOR GENE-THERAPY FOR CANCER
Authors: NIELSEN LL MANEVAL DC
Citation: Ll. Nielsen et Dc. Maneval, P53 TUMOR-SUPPRESSOR GENE-THERAPY FOR CANCER, Cancer gene therapy, 5(1), 1998, pp. 52-63
P53-MEDIATED ACCUMULATION OF HYPOPHOSPHORYLATED PRB AFTER THE G(1) RESTRICTION POINT FAILS TO HALT CELL-CYCLE PROGRESSION
Authors: LINKE SP HARRIS MP NEUGEBAUER SE CLARKIN KC SHEPARD HM MANEVAL DC WAHL GM
Citation: Sp. Linke et al., P53-MEDIATED ACCUMULATION OF HYPOPHOSPHORYLATED PRB AFTER THE G(1) RESTRICTION POINT FAILS TO HALT CELL-CYCLE PROGRESSION, Oncogene, 15(3), 1997, pp. 337-345
INTRAARTERIAL P53 GENE-THERAPY OF LIVER MALIGNANCIES - PRECLINICAL STUDIES AND INITIAL CLINICAL OBSERVATIONS
Authors: HOROWITZ JA MANEVAL DC RYBAK ME JOHNSON D HARRIS MP DEMERS GW ANDERSON S VENOOK A WARREN R
Citation: Ja. Horowitz et al., INTRAARTERIAL P53 GENE-THERAPY OF LIVER MALIGNANCIES - PRECLINICAL STUDIES AND INITIAL CLINICAL OBSERVATIONS, Cancer gene therapy, 4(6), 1997, pp. 3-3
SYSTEMIC RB-LIPID GENE-THERAPY OF A METASTATIC SMALL-CELL LUNG-CANCERIN IMMUNODEFICIENT MICE RESULTS IN EXTENDED SURVIVAL
Authors: ANTELMAN D SCHEULE RK JOHNSON D BAGLEY R WEN SF MARSHALL J MACHEMER T HARRIS D CHENG SH MANEVAL DC
Citation: D. Antelman et al., SYSTEMIC RB-LIPID GENE-THERAPY OF A METASTATIC SMALL-CELL LUNG-CANCERIN IMMUNODEFICIENT MICE RESULTS IN EXTENDED SURVIVAL, Cancer gene therapy, 4(6), 1997, pp. 9-9
CHARACTERIZATION OF AN IMMUNODEFICIENT MOUSE MODEL OF HUMAN SMALL-CELL LUNG-CANCER (SCLC) FOR TUMOR-SUPPRESSOR GENE-THERAPY
Authors: JOHNSON D MACHEMER T HANCOCK W WEN SF MANEVAL DC
Citation: D. Johnson et al., CHARACTERIZATION OF AN IMMUNODEFICIENT MOUSE MODEL OF HUMAN SMALL-CELL LUNG-CANCER (SCLC) FOR TUMOR-SUPPRESSOR GENE-THERAPY, Cancer gene therapy, 4(6), 1997, pp. 33-33
KINETICS OF BIODISTRIBUTION AND ADENOVIRUS-RB EXPRESSION AFTER INTRAVESICAL ADMINISTRATION TO MICE
Authors: MACHEMER T ENGLER H LOFGREN S WEN SF HUTCHINS B MANEVAL DC
Citation: T. Machemer et al., KINETICS OF BIODISTRIBUTION AND ADENOVIRUS-RB EXPRESSION AFTER INTRAVESICAL ADMINISTRATION TO MICE, Cancer gene therapy, 4(6), 1997, pp. 75-75
OPTIMAL CONDITIONS FOR THE ADENOVIRUS-P53 PURGING OF HUMAN PERIPHERAL-BLOOD STEM-CELL PRODUCTS
Authors: TALMADGE JE HIRAI M KELSEY L QIAN F WATANABE T VAILLANCOURT M MANEVAL DC
Citation: Je. Talmadge et al., OPTIMAL CONDITIONS FOR THE ADENOVIRUS-P53 PURGING OF HUMAN PERIPHERAL-BLOOD STEM-CELL PRODUCTS, Cancer gene therapy, 4(6), 1997, pp. 80-80
ADENOVIRUS-P53 MEDIATED TRANSDUCTION OF HUMAN CD34-CELLS( STEM)
Authors: TALMADGE JE WATANABE T HIRAI M KELSEY L KUSZYNSKI C VAILLANCOURT M MANEVAL DC
Citation: Je. Talmadge et al., ADENOVIRUS-P53 MEDIATED TRANSDUCTION OF HUMAN CD34-CELLS( STEM), Cancer gene therapy, 4(6), 1997, pp. 81-81
IN-VITRO ANALYSIS OF THE COMBINATION OF P53 GENE-THERAPY AND DOXORUBICIN ON HEPATOCELLULAR-CARCINOMA CELL-LINES
Authors: DEMERS GW NEUGEBAUER S JOHNSON D MANEVAL DC
Citation: Gw. Demers et al., IN-VITRO ANALYSIS OF THE COMBINATION OF P53 GENE-THERAPY AND DOXORUBICIN ON HEPATOCELLULAR-CARCINOMA CELL-LINES, Hepatology, 26(4), 1997, pp. 1478-1478
OPTIMAL CONDITIONS FOR THE ADENOVIRUS-P53 PURGING OF BREAST-CANCER STEM-CELL PRODUCTS
Authors: HIRAI M KELSEY L QIAN F VAILLANCOURT M MANEVAL DC TALMADGE JE
Citation: M. Hirai et al., OPTIMAL CONDITIONS FOR THE ADENOVIRUS-P53 PURGING OF BREAST-CANCER STEM-CELL PRODUCTS, Blood, 90(10), 1997, pp. 949-949
ADENOVIRAL-MEDIATED P53 TUMOR-SUPPRESSOR GENE-THERAPY OF HUMAN OVARIAN-CARCINOMA
Authors: MUJOO K MANEVAL DC ANDERSON SC GUTTERMAN JU
Citation: K. Mujoo et al., ADENOVIRAL-MEDIATED P53 TUMOR-SUPPRESSOR GENE-THERAPY OF HUMAN OVARIAN-CARCINOMA, Oncogene, 12(8), 1996, pp. 1617-1623
HIGH-EFFICIENCY ADENOVIRUS-MEDIATED GENE-TRANSFER INTO HUMAN CD34-CELLS( HEMATOPOIETIC)
Authors: WATANABE T KUSZYNSKI C INO K HEIMANN DG VAILLANCOURT M SHEPARD HM MANEVAL DC TALMADGE JE
Citation: T. Watanabe et al., HIGH-EFFICIENCY ADENOVIRUS-MEDIATED GENE-TRANSFER INTO HUMAN CD34-CELLS( HEMATOPOIETIC), Cancer gene therapy, 3(6), 1996, pp. 63-63
ADENOVIRUS-MEDIATED P53 GENE-TRANSFER INHIBITS GROWTH OF HUMAN TUMOR-CELLS EXPRESSING MUTANT P53 PROTEIN
Authors: HARRIS MP SUTJIPTO S WILLS KN HANCOCK W CORNELL D JOHNSON DE GREGORY RJ SHEPARD HM MANEVAL DC
Citation: Mp. Harris et al., ADENOVIRUS-MEDIATED P53 GENE-TRANSFER INHIBITS GROWTH OF HUMAN TUMOR-CELLS EXPRESSING MUTANT P53 PROTEIN, Cancer gene therapy, 3(2), 1996, pp. 121-130
ADENOVIRUS-MEDIATED P53 GENE-TRANSFER SUPPRESSES GROWTH OF HUMAN GLIOBLASTOMA CELLS IN-VITRO AND IN-VIVO
Authors: KOCK H HARRIS MP ANDERSON SC MACHEMER T HANCOCK W SUTJIPTO S WILLS KN GREGORY RJ SHEPARD HM WESTPHAL M MANEVAL DC
Citation: H. Kock et al., ADENOVIRUS-MEDIATED P53 GENE-TRANSFER SUPPRESSES GROWTH OF HUMAN GLIOBLASTOMA CELLS IN-VITRO AND IN-VIVO, International journal of cancer, 67(6), 1996, pp. 808-815
GENE-THERAPY FOR HEPATOCELLULAR-CARCINOMA - CHEMOSENSITIVITY CONFERRED BY ADENOVIRUS-MEDIATED TRANSFER OF THE HSV-1 THYMIDINE KINASE GENE
Authors: WILLS KN HUANG WM HARRIS MP MACHEMER T MANEVAL DC GREGORY RJ
Citation: Kn. Wills et al., GENE-THERAPY FOR HEPATOCELLULAR-CARCINOMA - CHEMOSENSITIVITY CONFERRED BY ADENOVIRUS-MEDIATED TRANSFER OF THE HSV-1 THYMIDINE KINASE GENE, Cancer gene therapy, 2(3), 1995, pp. 191-197
RECOMBINANT ADENOVIRUS-MEDIATED GENE-TRANSFER TO GENITOURINARY EPITHELIUM IN-VITRO AND IN-VIVO
Authors: BASS C CABRERA G ELGAVISH A ROBERT B SIEGAL GP ANDERSON SC MANEVAL DC CURIEL DT
Citation: C. Bass et al., RECOMBINANT ADENOVIRUS-MEDIATED GENE-TRANSFER TO GENITOURINARY EPITHELIUM IN-VITRO AND IN-VIVO, Cancer gene therapy, 2(2), 1995, pp. 97-104
TREATMENT OF HEPATOCELLULAR-CARCINOMA THROUGH ADENOVIRUS-MEDIATED GENE-TRANSFER OF THE HSV-TK GENE IN COMBINATION WITH THE NUCLEOSIDE ANALOG DRUG GANCICLOVIR
Authors: WILLS KN HARRIS MP HUANG WM MACHEMER T MANEVAL DC GREGORY RJ
Citation: Kn. Wills et al., TREATMENT OF HEPATOCELLULAR-CARCINOMA THROUGH ADENOVIRUS-MEDIATED GENE-TRANSFER OF THE HSV-TK GENE IN COMBINATION WITH THE NUCLEOSIDE ANALOG DRUG GANCICLOVIR, Journal of cellular biochemistry, 1995, pp. 429-429
HIGH-EFFICIENCY ADENOVIRUS-MEDIATED GENE-TRANSFER INTO HUMAN CD34(-CELLS() HEMATOPOIETIC)
Authors: WATANABE T KUSZYNSKI C INO K HEIMANN DG MANEVAL DC TALMADGE JE
Citation: T. Watanabe et al., HIGH-EFFICIENCY ADENOVIRUS-MEDIATED GENE-TRANSFER INTO HUMAN CD34(-CELLS() HEMATOPOIETIC), Blood, 86(10), 1995, pp. 4017-4017
DEVELOPMENT AND CHARACTERIZATION OF RECOMBINANT ADENOVIRUSES ENCODINGHUMAN P53 FOR GENE-THERAPY OF CANCER
Authors: WILLS KN MANEVAL DC MENZEL P HARRIS MP SUTJIPTO S VAILLANCOURT MT HUANG WM JOHNSON DE ANDERSON SC WEN SF BOOKSTEIN R SHEPARD HM GREGORY RJ
Citation: Kn. Wills et al., DEVELOPMENT AND CHARACTERIZATION OF RECOMBINANT ADENOVIRUSES ENCODINGHUMAN P53 FOR GENE-THERAPY OF CANCER, Human gene therapy, 5(9), 1994, pp. 1079-1088
RECOMBINANT P53 ADENOVIRUS (RAD P53) EFFECTS ON PROLIFERATION OF HUMAN TUMOR-CELL LINES/
Authors: MANEVAL DC HARRIS MP SUTJIPTO S WEN SF HANCOCK W HUTCHINS BM WILLS KN GREGORY RJ
Citation: Dc. Maneval et al., RECOMBINANT P53 ADENOVIRUS (RAD P53) EFFECTS ON PROLIFERATION OF HUMAN TUMOR-CELL LINES/, Journal of cellular biochemistry, 1994, pp. 115-115
TUMOR-SUPPRESSOR GENE-THERAPY OF CANCER - ADENOVIRAL MEDIATED GENE-TRANSFER OF P53 AND RETINOBLASTOMA CDNA INTO HUMAN TUMOR-CELL LINES
Authors: WILLS KN MANEVAL DC MENZEL P SUTJIPTO S WEN SF NAREDHOOD K HARRIS MP HUANG WM VAILLANCOURT MT HANCOCK W MOULTON M NODELMAN M GREGORY RJ
Citation: Kn. Wills et al., TUMOR-SUPPRESSOR GENE-THERAPY OF CANCER - ADENOVIRAL MEDIATED GENE-TRANSFER OF P53 AND RETINOBLASTOMA CDNA INTO HUMAN TUMOR-CELL LINES, Journal of cellular biochemistry, 1994, pp. 204-204
Risultati: 1-25 | 26-26